Optimal Antipsychotic Dose for Schizophrenia Relapse Identified
Dr Stefan Leucht A middle-of-the-road dose of an antipsychotic appears to be optimal for relapse prevention in stable schizophrenia, new […]
Results from a large study make a strong case for offering long-acting injectable antipsychotics (LAIs) to patients newly diagnosed with […] A novel therapy that combines a muscarinic receptor agonist with an anticholinergic agent is associated with a greater reduction in […]antipsychotics
Long-Acting Injectable Antipsychotics Cut Suicide Death Risk in Half
‘Landmark’ Schizophrenia Drug in the Wings?